Societies Establish New Approach To Cardiac Tech Quality Measures
This article was originally published in The Gray Sheet
Executive SummaryU.S. cardiology societies staked out a path last week to develop publicly reportable quality measures for cardiovascular technologies that don’t have gold-standard randomized trial evidence backing them but have been widely adopted nonetheless.
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.